Revvity Inc.

Revvity Inc. is a for-profit corporation specializing in medical imaging, scientific instrumentation, and advanced research technologies. Through its Medical Imaging, LLC Division and various subsidiaries like Revvity Health Sciences, Euroimmun US Incorporated, and Revvity Signals Software, the company provides a wide range of products and services to federal government agencies. These offerings include laboratory equipment, medical diagnostic tools, scientific software, maintenance services, and specialized research technologies across multiple scientific domains. The company has a robust federal contract portfolio demonstrating its capability to support scientific research, medical diagnostics, and technical infrastructure across numerous government agencies.

Revvity Inc. has provided an extensive array of goods and services through federal contract awards, primarily focused on scientific and medical technologies. Their contract work spans multiple agencies including the National Institutes of Health, Centers for Disease Control and Prevention, Department of Defense, Department of Veterans Affairs, and Department of Commerce. Specific contract offerings include medical imaging devices like cell counters, spectrometers, and cytometers; scientific software such as ChemOffice and ChemDraw; laboratory equipment maintenance and repair services; newborn screening testing services; and specialized research instrumentation. These contracts are typically firm fixed-price purchase orders or delivery orders, and are consistently awarded without small business set-aside designations. The company has worked with prime contractors like Lockheed Martin, Leidos, and Battelle Memorial Institute, demonstrating its versatility in supporting complex scientific and technological initiatives.

The provided contract documentation does not explicitly detail federal grant awards for Revvity Inc. The company's federal contract portfolio appears to be primarily focused on providing goods and services through direct purchase orders and delivery orders, rather than grant-based research funding. Their work is predominantly centered on delivering scientific equipment, maintenance services, and technological solutions to support research initiatives across various federal agencies.

Revvity Inc. holds several notable federal contract Indefinite Delivery Vehicles (IDVs) that underscore its specialized capabilities. These include a single-award Indefinite Delivery Contract with the Defense Health Agency for newborn screening testing services at the Brian D. Allgood Army Community Hospital in South Korea, valued at $301,668 with a performance period through September 2029. Another significant IDV is a $2.4 million contract with the Department of the Army Medical Command for immunodiagnostic systems reagents and supplies, running from January 2024 through January 2029. Additionally, they have a Blanket Purchase Agreement with the U.S. Air Force in Europe - Air Forces Africa for newborn metabolic screening test services at Spangdahlem Air Base in Germany, with a $150,000 potential value through September 2028. These IDVs demonstrate Revvity's strategic positioning in providing specialized medical testing and screening services to military and federal healthcare institutions.